HUM Humana Inc. Common Stock
Humana Inc. Common Stock について Wikipediaからの企業概要
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
続きを読む
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S.
History
1961–1983: Nursing homes and hospitals
Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).
In 1974, the partners changed the corporate name to Humana Inc. The name was meant to change public perception from 'warehousing' or indifferently treating people to providing a higher level of human care and, by extension, more humane care. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s. During this period, Humana developed the double corridor model for hospital construction. This design minimized the distance between patients and nurses by placing nursing support services in the interior of the building with patient rooms surrounding the perimeter.
1984–present
As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."
In 1993, Humana had become the largest hospital operator in the country, owning 77 hospitals. Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.
In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value. In 2001, Humana was a cofounder of Availity.
In 2005, Humana entered into a business partnership with Virgin Group, offering financial incentives to members for healthy behavior, such as regular exercise.
On November 16, 2006, the Centers for Disease Control and Prevention (CDC) and Humana Inc. partnered to expand on traditional private-sector approaches to population health management.
In 2010, Humana bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million, effectively returning to healthcare services. In May 2011, Humana announced it would be using mobileStorm to transmit protected health information to patients.
In March 2015, Humana announced the sale of Concentra to private equity firm Welsh, Carson, Anderson & Stowe and Select Medical Holdings Corporation for about $1 billion, with proceeds to fund a "$2 billion share buyback program and other corporate spending."
In July 2015, Aetna announced that it would acquire Humana for $37 billion in cash and stock (approximately $230 a share at that time). Aetna and Humana shareholders would own 74% and 26% of the new combined company. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna Inc. and Humana Inc. quashed a $34 billion merger agreement after judges ruled against the merger for a second time.
In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million. In August 2018, Humana announced the creation of a digital health and analytics division called Humana Studio H.
In December 2019, the company announced it would acquire Enclara Healthcare from Consonance Capital Partners and Enclara management.
In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO. Her appointment to the position comes with the company's focus being turned towards the home healthcare business, acquiring in April of the same year a 60% stake in Kindred at Home, an in-home care and hospice business.
In April 2022, it was announced Humana would sell a 60% interest of its Kindred at Home division to the private investment company, Clayton, Dubilier & Rice, for US$2.8 billion.
In February 2023, Humana announced they were exiting the employer-based commercial group insurance market.
Corporate affairs
Sponsorship
Humana is the presenting sponsor of the Grand Ole Opry and the National Senior Games.
Since 1979, Humana has been a principal sponsor of the annual Humana Festival of New American Plays in Louisville, Kentucky.
Humana was a tour partner of the PGA Tour beginning from 2005 to 2015.
The Humana Distaff Handicap is a Grade 1 race for thoroughbred fillies and mares, four-years-old and up. The race is run each spring on Kentucky Derby day at Churchill Downs and set at a distance of 7 furlongs for a purse of $250,000.
Humana Military Healthcare Services
In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.
From 2004 to 2009, HMHS was the managed care contractor for the Department of Defense Military Health System TRICARE South Region.
In 2009, HMHS' Managed Care Support Contract was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.
In 2011, HMHS regained the five-year contract to administer medical benefits to military members and families in the South region, a contract worth $23.5 billion. In 2018, this was moved to the new TRICARE East region during the TRICARE regional realignment.
On December 22, 2022, the Department of Defense announced the award of the managed care support contract for the TRICARE East Region to Humana Military.
Legal campaign against drug price fixing
Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.
Controversy
In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.
On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.
In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.
Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.
On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
HUM 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
HUM 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
成長 収益、EPS、純利益の成長率:前年比、3年CAGR、5年CAGR
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
配当金 利回り、配当性向、配当履歴、5年CAGR
| 権利落ち日 | 金額 |
|---|---|
| 2026年6月26日 | $0.8850 |
| 2026年3月27日 | $0.8850 |
| 2025年12月26日 | $0.8850 |
| 2025年9月26日 | $0.8850 |
| 2025年6月27日 | $0.8850 |
| 2025年3月28日 | $0.8850 |
| 2024年12月31日 | $0.8850 |
| 2024年9月30日 | $0.8850 |
| 2024年6月28日 | $0.8850 |
| 2024年3月27日 | $0.8850 |
| 2023年12月28日 | $0.8850 |
| 2023年9月28日 | $0.8850 |
| 2023年6月29日 | $0.8850 |
| 2023年3月30日 | $0.8850 |
| 2022年12月29日 | $0.7880 |
| 2022年9月29日 | $0.7880 |
| 2022年6月29日 | $0.7880 |
| 2022年3月30日 | $0.7880 |
| 2021年12月30日 | $0.7000 |
| 2021年9月29日 | $0.7000 |
HUM アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
- 強い買い 8 24.2%
- 買い 8 24.2%
- 保有 15 45.5%
- 売り 2 6.1%
- 強い売り 0 0.0%
12ヶ月目標株価
23 アナリスト · 2026-08-19決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $7.61 | $7.29 | 0.32% |
| 2026年3月31日 | $10.31 | $10.29 | 0.02% |
| 2025年12月31日 | $-3.96 | $-4.05 | 0.09% |
| 2025年9月30日 | $3.24 | $2.85 | 0.39% |
| 2025年6月30日 | $6.27 | $5.98 | 0.29% |
| 2025年3月31日 | $11.58 | $10.17 | 1.4% |
同業他社比較(GICSサブインダストリー) 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 13
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| SG&A Expense | $15.45B | $13.70B | $13.19B | $12.67B | $10.12B | $10.05B | $7.38B | $7.53B | $6.57B | $7.17B | $7.29B | $7.64B | |
| Operating Income | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B | |
| Interest Expense | · | · | $493M | $401M | $326M | $283M | $242M | $218M | $242M | $189M | $186M | $192M | |
| Other Non-op | $-451M | $-181M | $-137M | $-68M | $532M | $-103M | $506M | $-33M | $0 | $0 | · | · | |
| Pretax Income | $1.44B | $1.62B | $3.33B | $3.57B | $3.42B | $4.67B | $3.47B | $2.07B | $4.02B | $1.55B | $2.43B | $2.17B | |
| Income Tax | $250M | $413M | $836M | $762M | $485M | $1.31B | $763M | $391M | $1.57B | $938M | $1.16B | $1.02B | |
| Net Income | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| EPS (Basic) | $9.87 | $10.01 | $20.09 | $22.20 | $22.79 | $25.47 | $20.20 | $12.24 | $16.94 | $4.11 | $8.54 | $7.44 | |
| EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 | $25.31 | $20.10 | $12.16 | $16.81 | $4.07 | $8.44 | $7.36 | |
| Shares (Basic) | 120,454,000 | 120,571,000 | 123,866,000 | 126,419,000 | 128,688,000 | 132,199,000 | 134,055,000 | 137,486,000 | 144,493,000 | 149,375,000 | 149,455,000 | 154,187,000 | |
| Shares (Diluted) | 120,826,000 | 120,869,000 | 124,441,000 | 127,094,000 | 129,396,000 | 133,012,000 | 134,727,000 | 138,403,000 | 145,585,000 | 150,917,000 | 151,142,000 | 155,874,000 | |
| EBITDA | $2.70B | $2.56B | $4.01B | $3.80B | $3.15B | $4.99B | $3.19B | $3.10B | $4.26B | $1.74B | $2.35B | $2.36B |
貸借対照表 26
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B | $3.39B | $4.67B | $4.05B | $2.34B | $4.04B | $3.88B | $2.57B | $1.94B | |
| Short-term Investments | $15.70B | $18.21B | $16.63B | $13.88B | $13.19B | $12.55B | $10.97B | · | · | · | · | · | |
| Receivables | $3.27B | $2.70B | $2.04B | $1.67B | $1.81B | $1.14B | $1.06B | $1.01B | $854M | $1.28B | $1.16B | $1.05B | |
| Other Current Assets | $9.56B | $6.68B | $6.63B | $5.57B | $6.49B | $5.28B | $3.81B | $3.56B | $2.95B | $3.44B | $4.71B | $4.01B | |
| Current Assets | $32.73B | $29.82B | $29.99B | $26.18B | $24.89B | $23.64B | $19.89B | $16.95B | $17.40B | $16.19B | $15.71B | $15.54B | |
| PP&E (Net) | $2.23B | $2.53B | $3.03B | $3.22B | $3.07B | $2.37B | $1.96B | $1.74B | $1.58B | $1.50B | $1.38B | $1.23B | |
| PP&E (Gross) | $5.52B | $5.67B | $5.88B | $6.36B | $5.95B | $5.49B | $4.62B | $4.05B | $3.56B | $3.19B | $2.72B | $2.91B | |
| Accum. Depreciation | $3.29B | $3.14B | $2.85B | $3.14B | $2.87B | $3.12B | $2.66B | $2.31B | $1.98B | $1.69B | $1.34B | $1.68B | |
| Goodwill | $9.69B | $9.63B | $9.55B | $9.14B | $11.09B | $4.45B | $3.93B | $3.90B | $3.28B | $3.27B | $3.27B | $3.23B | |
| Intangibles | $1.13B | $1.44B | $1.69B | $1.76B | $2.64B | $329M | $177M | $245M | $226M | $280M | $357M | $440M | |
| Other Non-current Assets | $3.13B | $3.38B | $3.38B | $3.38B | $4.38B | $2.13B | $1.83B | $1.38B | $2.17B | $2.23B | $2.48B | $1.58B | |
| Total Assets | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Accounts Payable | $5.72B | $5.26B | $6.57B | $5.24B | $4.51B | $4.01B | $3.75B | $3.07B | $4.07B | $2.47B | $2.21B | $2.10B | |
| Short-term Debt | · | · | · | · | · | · | · | $1.69B | $150M | $300M | $299M | $0 | |
| Current Liabilities | $16.35B | $16.94B | $18.87B | $17.18B | $15.33B | $13.39B | $10.93B | $10.08B | $9.41B | $7.82B | $8.15B | $7.47B | |
| Capital Leases | $418M | $392M | $444M | $456M | $546M | $355M | $332M | · | · | · | · | · | |
| Other Non-current Liabilities | $2.46B | $1.95B | $1.66B | $1.47B | $2.38B | $1.79B | $1.14B | $581M | $237M | $263M | $235M | $236M | |
| Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B | $28.25B | $21.24B | $17.04B | $15.25B | $17.34B | $14.71B | $14.33B | $13.88B | |
| Total Debt | $12.37B | $11.14B | $10.21B | $9.03B | $10.54B | $6.06B | $4.97B | $6.07B | $4.92B | $4.09B | $4.12B | $3.83B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | |
| Retained Earnings | $29.07B | $28.32B | $27.54B | $25.49B | $23.09B | $20.52B | $17.48B | $15.07B | $13.67B | $11.45B | $11.02B | $9.92B | |
| Treasury Stock | $14.42B | $14.37B | $13.66B | $12.16B | $10.16B | $9.92B | $8.46B | $7.32B | $6.33B | $3.30B | $3.29B | $2.86B | |
| AOCI | $-633M | $-1.07B | $-999M | $-1.30B | $42M | $391M | $156M | $-159M | $19M | $-66M | $58M | $223M | |
| Stockholders' Equity | $17.66B | $16.38B | $16.26B | $15.31B | $16.08B | $13.73B | $12.04B | $10.16B | $9.84B | $10.69B | $10.35B | $9.65B | |
| Liabilities + Equity | $48.91B | $46.48B | $47.06B | $43.05B | $44.36B | $34.97B | $29.07B | $25.41B | $27.18B | $25.40B | $24.68B | $23.53B | |
| Shares Outstanding | 198,719,000 | 198,719,000 | 198,690,000 | 198,667,000 | 198,649,000 | 198,649,000 | 198,630,000 | · | · | · | · | · |
キャッシュフロー 17
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $698M | $839M | $779M | $709M | $596M | · | · | $444M | $410M | $388M | $354M | $328M | |
| Stock-based Comp | $241M | $207M | $175M | $216M | $180M | $181M | $163M | $137M | $157M | $115M | $109M | $98M | |
| Deferred Tax | $75M | $-192M | $-164M | $-100M | $15M | $195M | $162M | $194M | $132M | $-71M | $-2M | $-64M | |
| Amort. of Intangibles | $51M | $60M | $67M | $81M | $65M | $88M | $70M | $90M | $75M | $77M | $93M | $121M | |
| Restructuring | · | · | · | · | · | · | $47M | · | $148M | · | · | · | |
| Operating Cash Flow | $921M | $2.97B | $3.98B | $4.59B | $2.26B | $5.64B | $5.28B | $2.17B | $4.05B | $1.94B | $868M | $1.62B | |
| CapEx | $546M | $575M | $1.00B | $1.14B | $1.34B | $964M | $736M | $612M | $524M | $527M | $523M | $528M | |
| Investing Cash Flow | $2.27B | $-2.95B | $-3.49B | $-1.01B | $-6.56B | $-3.06B | $-1.28B | $-3.09B | $-2.94B | $-1.36B | $320M | $-63M | |
| Net Debt Issued | · | · | · | · | · | · | $-400M | $0 | $-800M | $0 | $0 | $-500M | |
| Stock Repurchased | $151M | $817M | $1.57B | $2.10B | $79M | $1.82B | $1.07B | $1.09B | $3.37B | $104M | $385M | $872M | |
| Net Stock Activity | $-151M | $-817M | $-1.57B | $-2.10B | $-79M | $-1.82B | $-1.07B | $-1.09B | $-3.37B | $-104M | $-385M | $-872M | |
| Dividends Paid | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M | |
| Financing Cash Flow | $-1.22B | $-2.49B | $-856M | $-1.91B | $3.02B | $-1.96B | $-2.29B | $-785M | $-945M | $732M | $-552M | $-758M | |
| Net Change in Cash | $1.98B | $-2.47B | $-367M | $1.67B | $-1.28B | $619M | $1.71B | $-1.70B | $165M | $1.31B | $636M | $797M | |
| Taxes Paid | · | $570M | $997M | $758M | $227M | $1.13B | $518M | $631M | $1.50B | $916M | $1.18B | $1.03B | |
| Free Cash Flow | $375M | $2.39B | $2.98B | $3.47B | $946M | $4.67B | $4.55B | $1.56B | $3.52B | $1.41B | $345M | $1.09B | |
| Levered FCF | · | · | $2.61B | $3.15B | $666M | $4.47B | $4.36B | $1.38B | $3.38B | $1.33B | $247M | $989M |
収益性 7
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| Net Margin | 0.92% | 1.0% | 2.3% | 3.0% | 3.5% | 4.4% | 4.2% | 3.0% | 4.5% | 1.1% | 2.4% | 2.4% | |
| Pretax Margin | 1.1% | 1.5% | 3.1% | 3.8% | 4.1% | 6.1% | 5.3% | 3.6% | 7.5% | 2.9% | 4.5% | 4.5% | |
| EBITDA Margin | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% | 6.5% | 4.9% | 5.5% | 7.9% | 3.2% | 4.3% | 4.9% | |
| ROA | 2.5% | 2.6% | 5.5% | 6.4% | 7.4% | 10.5% | 9.9% | 6.4% | 9.3% | 2.5% | 5.3% | 5.2% | |
| ROE | 7.0% | 7.4% | 15.8% | 18.2% | 18.1% | 22.8% | 22.9% | 16.2% | 23.3% | 5.8% | 12.8% | 12.1% | |
| ROIC | 7.4% | 7.1% | 11.3% | 12.3% | 10.1% | 18.1% | 14.6% | 15.5% | 17.6% | 4.7% | 8.5% | 9.3% |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 | 1.8 | 1.8 | 1.7 | 1.9 | 2.1 | 1.9 | 2.0 | |
| Quick Ratio | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 | 1.4 | 0.5 | 0.3 | 0.5 | 0.7 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 | |
| Interest Coverage | · | · | 8.1 | 9.5 | 9.7 | 17.6 | 13.2 | 14.2 | 17.6 | 9.2 | 12.6 | 12.3 |
効率性 2
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 2.7 | 2.5 | 2.4 | 2.1 | 2.1 | 2.4 | 2.4 | 2.2 | 2.0 | 2.2 | 2.3 | 2.2 | |
| Receivables Turnover | 43.4 | 49.7 | 57.4 | 53.3 | 56.3 | 70.3 | 62.7 | 60.9 | 50.4 | 44.6 | 49.0 | 45.8 |
成長率 10
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 10.7% | 14.5% | 11.8% | 7.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.8% | 12.3% | 11.3% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.4% | -50.1% | -9.4% | -2.6% | -10.4% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -23.6% | -23.9% | -7.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.6% | -51.5% | -11.3% | -4.3% | -12.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -24.9% | -25.6% | -9.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -18.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · |
バリュエーション(TTM) 17
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B | $77.16B | $64.89B | $56.91B | $53.77B | $54.38B | $54.29B | $48.50B | |
| Net Income TTM | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B | $3.37B | $2.71B | $1.68B | $2.45B | $614M | $1.28B | $1.15B | |
| Market Cap | $50.90B | $50.42B | $90.96B | $101.76B | · | · | · | · | · | · | · | · | |
| Enterprise Value | $43.36B | $41.13B | $79.86B | $91.85B | · | · | · | · | · | · | · | · | |
| P/E | 26.0 | 25.4 | 22.9 | 23.2 | 20.5 | 16.2 | 18.2 | 23.6 | 14.8 | 50.1 | 21.2 | 19.5 | |
| P/S | 0.4 | 0.4 | 0.9 | 1.1 | · | · | · | · | · | · | · | · | |
| P/B | 2.9 | 3.1 | 5.6 | 6.6 | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 7.4 | 9.5 | 18.1 | 23.1 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.3 | 17.0 | 22.8 | 22.2 | · | · | · | · | · | · | · | · | |
| P / FCF | 135.7 | 21.1 | 30.6 | 29.3 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 16.0 | 16.1 | 19.9 | 24.2 | · | · | · | · | · | · | · | · | |
| EV / FCF | 115.6 | 17.2 | 26.8 | 26.5 | · | · | · | · | · | · | · | · | |
| EV / Revenue | 0.3 | 0.3 | 0.8 | 1.0 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 0.84% | 0.85% | 0.47% | 0.39% | · | · | · | · | · | · | · | · | |
| Earnings Yield | 3.8% | 3.9% | 4.4% | 4.3% | 4.9% | 6.2% | 5.5% | 4.2% | 6.8% | 2.0% | 4.7% | 5.1% | |
| Payout Ratio | 36.2% | 35.7% | 17.3% | 14.0% | 12.1% | 9.6% | 10.8% | 15.8% | 9.0% | 28.8% | 13.5% | 15.0% | |
| Annual Payout | $430M | $431M | $431M | $392M | $354M | $323M | $291M | $265M | $220M | $177M | $172M | $172M |
損益計算書 13
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $40.87B | $39.65B | $32.52B | $32.65B | $32.39B | $32.11B | $29.21B | $29.40B | $29.54B | $29.61B | $26.46B | $26.42B | $26.75B | $26.74B | $22.44B | $22.80B | |
| SG&A Expense | $3.98B | $4.02B | $4.44B | $4.08B | $3.55B | $3.38B | $4.17B | $3.34B | $3.15B | $3.04B | $3.83B | $3.27B | $3.11B | $2.98B | $3.55B | $3.06B | |
| Operating Income | $1.36B | $1.75B | $-808M | $400M | $1.10B | $2.01B | $-543M | $728M | $1.14B | $1.24B | $-348M | $1.21B | $1.44B | $1.72B | $124M | $1.17B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $159M | · | $114M | $120M | $113M | · | $102M | |
| Other Non-op | $-211M | $34M | $-53M | $-35M | $-200M | $-163M | $-155M | $92M | $-55M | $-63M | $-97M | $6M | $-54M | $8M | $-84M | $-13M | |
| Pretax Income | $952M | $1.59B | $-1.13B | $134M | $741M | $1.69B | $-963M | $651M | $918M | $1.01B | $-610M | $1.09B | $1.25B | $1.60B | $-72M | $1.30B | |
| Income Tax | $238M | $395M | $-249M | $-86M | $179M | $406M | $-216M | $155M | $223M | $251M | $-75M | $256M | $296M | $359M | $-58M | $107M | |
| Net Income | $694M | $1.19B | $-796M | $195M | $545M | $1.24B | $-693M | $480M | $679M | $741M | $-541M | $832M | $959M | $1.24B | $-15M | $1.20B | |
| EPS (Basic) | $5.78 | $9.85 | $-6.58 | $1.62 | $4.52 | $10.31 | $-5.74 | $3.99 | $5.63 | $6.13 | $-4.26 | $6.74 | $7.70 | $9.91 | $-0.07 | $9.45 | |
| EPS (Diluted) | $5.73 | $9.83 | $-6.59 | $1.62 | $4.51 | $10.30 | $-5.73 | $3.98 | $5.62 | $6.11 | $-4.24 | $6.71 | $7.66 | $9.87 | $-0.08 | $9.39 | |
| Shares (Basic) | 120,066,000 | 120,332,000 | -241,024,000 | 120,273,000 | 120,539,000 | 120,666,000 | -241,257,000 | 120,405,000 | 120,445,000 | 120,978,000 | -249,139,000 | 123,426,000 | 124,574,000 | 125,005,000 | -253,614,000 | 126,572,000 | |
| Shares (Diluted) | 121,135,000 | 120,652,000 | -241,508,000 | 120,745,000 | 120,745,000 | 120,844,000 | -241,828,000 | 120,764,000 | 120,665,000 | 121,268,000 | -250,215,000 | 123,983,000 | 125,109,000 | 125,564,000 | -254,820,000 | 127,356,000 | |
| EBITDA | $1.36B | $1.75B | · | $400M | $1.10B | $2.01B | · | $728M | $1.14B | $1.24B | · | $1.21B | $1.44B | $1.72B | · | $1.17B |
貸借対照表 25
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.89B | $4.95B | $4.20B | $5.39B | $4.04B | $4.25B | $2.22B | $5.12B | $5.50B | $5.91B | · | $15.15B | $16.21B | $13.73B | · | $13.56B | |
| Short-term Investments | $16.98B | $17.01B | $15.70B | $16.74B | $17.67B | $17.89B | $18.21B | $19.03B | $17.42B | $16.70B | · | $15.14B | $15.25B | $14.93B | · | $13.12B | |
| Receivables | $5.70B | $5.22B | $3.27B | $2.68B | $4.50B | $4.46B | $2.70B | $2.14B | $4.09B | $3.92B | · | $1.82B | $1.43B | $3.11B | · | $1.61B | |
| Other Current Assets | $10.52B | $10.90B | $9.56B | $7.94B | $7.40B | $7.83B | $6.68B | $6.63B | $5.84B | $6.26B | · | $6.14B | $5.87B | $5.76B | · | $5.42B | |
| Current Assets | $40.09B | $38.08B | $32.73B | $32.75B | $33.62B | $34.42B | $29.82B | $32.93B | $32.86B | $32.80B | · | $38.25B | $38.76B | $37.53B | · | $33.71B | |
| PP&E (Net) | $2.10B | $2.17B | $2.23B | $2.27B | $2.36B | $2.43B | $2.53B | $2.69B | $2.82B | $2.98B | · | $3.34B | $3.31B | $3.23B | · | $3.22B | |
| PP&E (Gross) | · | · | $5.52B | · | · | · | $5.67B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $3.29B | · | · | · | $3.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $10.48B | $10.49B | $9.69B | $9.62B | $9.63B | $9.63B | $9.63B | $9.59B | $9.57B | $9.56B | $9.55B | $9.54B | $9.54B | $9.32B | $9.14B | $9.10B | |
| Intangibles | $1.18B | $1.19B | $1.13B | $1.23B | $1.38B | $1.43B | $1.44B | $1.65B | $1.66B | $1.68B | · | $1.76B | $1.78B | $1.75B | · | $1.80B | |
| Other Non-current Assets | $3.25B | $3.28B | $3.13B | $4.02B | $3.69B | $3.38B | $3.38B | $3.67B | $3.72B | $3.64B | · | $3.64B | $3.73B | $3.58B | · | $3.63B | |
| Total Assets | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Accounts Payable | $7.26B | $6.53B | $5.72B | $5.52B | $5.59B | $5.38B | $5.26B | $5.92B | $6.53B | $6.50B | · | $7.60B | $8.12B | $7.43B | · | $6.77B | |
| Current Liabilities | $23.01B | $21.51B | $16.35B | $16.18B | $17.22B | $18.04B | $16.94B | $18.73B | $19.79B | $19.69B | · | $27.82B | $28.28B | $26.94B | · | $25.05B | |
| Capital Leases | · | · | $418M | · | · | · | $392M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2.93B | $2.85B | $2.46B | $2.35B | $2.26B | $2.34B | $1.95B | $1.77B | $1.83B | $1.83B | · | $1.59B | $1.56B | $1.46B | · | $1.60B | |
| Total Liabilities | $37.92B | $36.63B | $31.17B | $31.14B | $32.06B | $33.11B | $30.03B | $32.38B | $33.37B | $33.91B | · | $38.90B | $39.56B | $38.14B | · | $34.45B | |
| Total Debt | $11.98B | $12.27B | · | $12.61B | $12.59B | $12.73B | · | $11.89B | $11.75B | $12.39B | · | $9.48B | $9.72B | $9.74B | · | $7.80B | |
| Common Stock | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | $33M | · | $33M | $33M | $33M | · | $33M | |
| Retained Earnings | $30.74B | $30.15B | $29.07B | $29.98B | $29.89B | $29.45B | $28.32B | $29.12B | $28.75B | $28.17B | · | $28.19B | $27.47B | $26.62B | · | $25.61B | |
| Treasury Stock | $14.51B | $14.52B | $14.42B | $14.46B | $14.46B | $14.36B | $14.37B | $14.40B | $14.40B | $14.36B | · | $13.13B | $12.75B | $12.22B | · | $11.15B | |
| AOCI | $-751M | $-731M | $-633M | $-666M | $-783M | $-868M | $-1.07B | $-653M | $-1.12B | $-1.09B | · | $-1.50B | $-1.23B | $-1.11B | · | $-1.47B | |
| Stockholders' Equity | $19.21B | $18.58B | $17.66B | $18.52B | $18.23B | $17.75B | $16.38B | $17.57B | $16.67B | $16.13B | · | $16.95B | $16.83B | $16.58B | · | $16.32B | |
| Liabilities + Equity | $57.20B | $55.28B | $48.91B | $49.72B | $50.36B | $50.93B | $46.48B | $50.01B | $50.09B | $50.09B | · | $55.91B | $56.45B | $54.78B | · | $50.77B | |
| Shares Outstanding | 198,720,000 | 198,720,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,719,000 | 198,691,000 | 198,690,000 | 198,690,000 | 198,690,000 | 198,667,000 | 198,667,000 | 198,667,000 |
キャッシュフロー 17
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $159M | $163M | $164M | $173M | $178M | $183M | $208M | $210M | $212M | $209M | $201M | $201M | $191M | $186M | · | · | |
| Stock-based Comp | $65M | $51M | $48M | $83M | $61M | $49M | $54M | $53M | $55M | $45M | $33M | $53M | $51M | $38M | $43M | $80M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | $-164M | $0 | · | · | $-67M | $-200M | |
| Amort. of Intangibles | $8M | $11M | $8M | $13M | $15M | $15M | $14M | $15M | $15M | $16M | $16M | $17M | $16M | $18M | $20M | $25M | |
| Operating Cash Flow | $1.97B | $1.25B | $-1.65B | $971M | $1.27B | $331M | $-528M | $1.86B | $1.21B | $423M | $-7.13B | $1.25B | $3.18B | $6.69B | $-5.13B | $8.45B | |
| CapEx | $132M | $121M | $202M | $135M | $114M | $95M | $154M | $130M | $114M | $177M | $283M | $234M | $264M | $223M | $275M | $288M | |
| Investing Cash Flow | $-273M | $-2.55B | $632M | $980M | $347M | $314M | $-63M | $-1.47B | $-1.00B | $-414M | $-882M | $-585M | $-733M | $-1.29B | $-1.01B | $1.68B | |
| Debt Issued | $0 | $990M | · | · | $0 | $1.48B | · | · | · | · | · | · | · | · | · | · | |
| Net Debt Issued | · | $980M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $1M | $107M | $42M | $0 | $100M | $9M | $49M | $2M | $49M | $717M | $571M | $379M | $529M | $94M | $1.06B | $4M | |
| Net Stock Activity | · | $-107M | · | · | · | $-9M | · | · | · | $-717M | · | · | · | $-94M | · | · | |
| Dividends Paid | $107M | $107M | $109M | $107M | $106M | $108M | $108M | $107M | $107M | $109M | $111M | $109M | $111M | $100M | $101M | $100M | |
| Financing Cash Flow | $249M | $2.05B | $-168M | $-603M | $-1.83B | $1.38B | $-2.30B | $-770M | $-620M | $1.21B | $-2.44B | $-1.73B | $36M | $3.28B | $-2.36B | $-1.79B | |
| Net Change in Cash | $1.94B | $751M | $-1.19B | $1.35B | $-210M | $2.03B | $-2.90B | $-385M | $-409M | $1.22B | $-10.45B | $-1.07B | $2.48B | $8.67B | $-8.50B | $8.34B | |
| Taxes Paid | $148M | $-7M | · | $122M | $41M | $-12M | · | $208M | $361M | $1M | · | $276M | $675M | $6M | $7M | $378M | |
| Free Cash Flow | · | $1.13B | · | · | · | $236M | · | · | · | $246M | · | · | · | $6.46B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $127M | · | · | · | $6.38B | · | · |
収益性 7
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| Net Margin | 1.7% | 3.0% | · | 0.60% | 1.7% | 3.9% | · | 1.6% | 2.3% | 2.5% | · | 3.1% | 3.6% | 4.6% | · | 5.2% | |
| Pretax Margin | 2.3% | 4.0% | · | 0.41% | 2.3% | 5.3% | · | 2.2% | 3.0% | 3.3% | · | 4.1% | 4.7% | 6.0% | · | 5.7% | |
| EBITDA Margin | 3.3% | 4.4% | · | 1.2% | 3.4% | 6.3% | · | 2.5% | 3.9% | 4.2% | · | 4.6% | 5.4% | 6.4% | · | 5.1% | |
| ROA | 1.3% | 2.2% | · | 0.39% | 1.1% | 2.5% | · | 0.91% | 1.3% | 1.4% | · | 1.6% | 1.9% | 2.5% | · | 2.5% | |
| ROE | 3.7% | 6.5% | · | 1.1% | 3.1% | 7.3% | · | 2.8% | 4.0% | 4.5% | · | 5.0% | 5.9% | 7.8% | · | 7.3% | |
| ROIC | 3.3% | 4.3% | · | 2.1% | 2.7% | 5.0% | · | 1.9% | 3.0% | 3.2% | · | 3.5% | 4.1% | 5.1% | · | 4.5% |
流動性と支払能力 5
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 1.8 | · | 2.0 | 2.0 | 1.9 | · | 1.8 | 1.7 | 1.7 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | 1.4 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.1 | |
| Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| LT Debt / Equity | 0.6 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 7.8 | · | 10.6 | 12.0 | 15.2 | · | 11.5 |
効率性 2
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | · | 0.7 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 8.0 | 8.2 | · | 13.5 | 7.5 | 7.7 | · | 14.8 | 10.7 | 8.4 | · | 15.4 | 11.1 | 8.5 | · | 13.1 |
バリュエーション(TTM) 15
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $145.55B | $136.80B | · | $126.55B | $123.44B | $120.66B | · | $114.97B | $112.32B | $109.52B | · | $102.71B | $99.95B | $97.17B | · | $91.13B | |
| Net Income TTM | $2.62B | $3.17B | · | $2.46B | $2.95B | $3.14B | · | $2.73B | $3.21B | $3.77B | · | $4.22B | $4.09B | $4.06B | · | $4.35B | |
| Market Cap | $78.94B | $34.46B | · | $51.70B | $48.58B | $52.58B | · | $62.94B | $74.25B | $68.89B | · | $96.67B | $88.84B | $96.44B | · | $96.39B | |
| Enterprise Value | $67.04B | $24.77B | · | $42.18B | $39.46B | $43.17B | · | $50.68B | $63.07B | $58.67B | · | $75.86B | $67.10B | $77.52B | · | $77.51B | |
| P/E | 18.3 | 6.6 | · | 12.7 | 10.0 | 10.2 | · | 14.1 | 14.3 | 11.4 | · | 14.5 | 13.8 | 15.2 | · | 14.3 | |
| P/S | 0.5 | 0.3 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.7 | 0.6 | · | 0.9 | 0.9 | 1.0 | · | 1.1 | |
| P/B | 4.1 | 1.9 | · | 2.8 | 2.7 | 3.0 | · | 3.6 | 4.5 | 4.3 | · | 5.7 | 5.3 | 5.8 | · | 5.9 | |
| P / Tangible Book | 10.5 | 5.0 | · | 6.7 | 6.7 | 7.9 | · | 10.0 | 13.6 | 14.1 | · | 17.1 | 16.1 | 17.5 | · | 17.8 | |
| P / Cash Flow | · | 27.5 | · | · | · | 158.9 | · | · | · | 162.9 | · | · | · | 14.4 | · | · | |
| P / FCF | · | 30.4 | · | · | · | 222.8 | · | · | · | 280.0 | · | · | · | 14.9 | · | · | |
| EV / EBITDA | 49.3 | 14.1 | · | 105.5 | 35.9 | 21.4 | · | 69.6 | 55.3 | 47.5 | · | 62.9 | 46.7 | 45.1 | · | 66.1 | |
| EV / FCF | · | 21.9 | · | · | · | 182.9 | · | · | · | 238.5 | · | · | · | 12.0 | · | · | |
| EV / Revenue | 0.5 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.6 | 0.5 | · | 0.7 | 0.7 | 0.8 | · | 0.9 | |
| Earnings Yield | 5.5% | 15.2% | · | 7.8% | 10.0% | 9.8% | · | 7.1% | 7.0% | 8.8% | · | 6.9% | 7.2% | 6.6% | · | 7.0% | |
| Payout Ratio | · | 9.0% | · | · | · | 8.7% | · | · | · | 14.7% | · | · | · | 8.1% | · | · |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $129.66B | $117.76B | $106.37B | $92.87B | $83.06B |
| 営業利益率 % | 2.1% | 2.2% | 3.8% | 4.1% | 3.8% |
| 純利益 | $1.19B | $1.21B | $2.49B | $2.81B | $2.93B |
| 希薄化後EPS | $9.84 | $9.98 | $20.00 | $22.08 | $22.67 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | 0.7 | 0.7 | 0.6 | 0.6 | 0.7 |
| 流動比率 | 2.0 | 1.8 | 1.6 | 1.5 | 1.6 |
| クイックレシオ | 1.4 | 1.4 | 1.2 | 1.2 | 1.2 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $375M | $2.39B | $2.98B | $3.47B | $946M |
最新ニュース この会社に言及した最近の見出し
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家(13F) 1,050 提出者 · $33.7B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 255 (+143 前期比) | 81 (-80 前期比) | 313 (+42 前期比) | 273 (-45 前期比) | +23.7M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| Dodge & Cox | $4,345,737,744 | 10,940,380 | 12.90% | 株式数 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3,115,642,737 | 7,843,620 | 9.25% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,311,405,702 | 5,818,956 | 6.86% | 株式数 |
| STATE STREET CORP | $2,172,441,313 | 5,457,072 | 6.45% | 株式数 |
| EAGLE CAPITAL MANAGEMENT LLC | $1,528,010,749 | 3,846,762 | 4.54% | 株式数 |
| Sessa Capital IM, L.P. | $1,480,732,883 | 3,727,740 | 4.40% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $1,181,074,714 | 2,976,242 | 3.51% | 株式数 |
| Capital International Investors | $950,462,637 | 2,392,826 | 2.82% | 株式数 |
| NAYA CAPITAL MANAGEMENT UK LTD | $728,407,339 | 1,833,763 | 2.16% | 株式数 |
| NORGES BANK | $694,505,009 | 1,748,414 | 2.06% | 株式数 |
| GOLDMAN SACHS GROUP INC | $659,096,868 | 1,659,274 | 1.96% | 株式数 |
| FMR LLC | $615,633,048 | 1,549,854 | 1.83% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $544,502,820 | 1,370,784 | 1.62% | 株式数 |
| Capital Research Global Investors | $443,462,035 | 1,116,990 | 1.32% | 株式数 |
| Slate Path Capital LP | $428,969,795 | 1,079,930 | 1.27% | 株式数 |
| Capital World Investors | $406,119,738 | 1,022,425 | 1.21% | 株式数 |
| Newport Trust Company, LLC | $384,768,345 | 968,653 | 1.14% | 株式数 |
| CITADEL ADVISORS LLC | $363,376,856 | 914,800 | 1.08% | コールオプション |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $348,908,912 | 878,377 | 1.04% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $331,490,508 | 834,526 | 0.98% | 株式数 |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC | $314,921,577 | 792,814 | 0.93% | 株式数 |
| CITADEL ADVISORS LLC | $310,904,094 | 782,700 | 0.92% | プットオプション |
| WELLINGTON MANAGEMENT GROUP LLP | $282,117,958 | 710,231 | 0.84% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $267,791,027 | 674,163 | 0.79% | 株式数 |
| Maple Rock Capital Partners Inc. | $249,553,862 | 628,251 | 0.74% | 株式数 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $245,555,446 | 618,185 | 0.73% | 株式数 |
| GOLDMAN SACHS GROUP INC | $232,333,978 | 584,900 | 0.69% | コールオプション |
| MARSHALL WACE, LLP | $216,873,381 | 545,978 | 0.64% | 株式数 |
| CITADEL ADVISORS LLC | $178,080,082 | 448,316 | 0.53% | 株式数 |
| High Ground Investment Management LLP | $177,941,848 | 447,968 | 0.53% | 株式数 |
| 1832 Asset Management L.P. | $176,401,430 | 444,090 | 0.52% | 株式数 |
| BCV Asset Management Inc. | $173,695,656 | 445,719 | 0.52% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $172,703,708 | 434,781 | 0.51% | 株式数 |
| Holocene Advisors, LP | $165,040,541 | 415,489 | 0.49% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $147,490,964 | 371,308 | 0.44% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $140,098,700 | 352,698 | 0.42% | 株式数 |
| JANE STREET GROUP, LLC | $137,080,622 | 345,100 | 0.41% | コールオプション |
| Swiss National Bank | $134,522,525 | 338,660 | 0.40% | 株式数 |
| JANE STREET GROUP, LLC | $122,542,370 | 308,500 | 0.36% | プットオプション |
| STEADFAST CAPITAL MANAGEMENT LP | $122,423,204 | 308,200 | 0.36% | 株式数 |
| BlackRock, Inc. | $120,890,332 | 304,341 | 0.36% | 株式数 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $115,565,201 | 290,935 | 0.34% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $109,135,401 | 274,748 | 0.32% | 株式数 |
| AMERIPRISE FINANCIAL INC | $108,302,217 | 272,614 | 0.32% | 株式数 |
| Legal & General Group Plc | $103,424,967 | 260,372 | 0.31% | 株式数 |
| Vanguard Global Advisers, LLC | $103,330,825 | 260,135 | 0.31% | 株式数 |
| GOLDMAN SACHS GROUP INC | $103,078,590 | 259,500 | 0.31% | プットオプション |
| NEUBERGER BERMAN GROUP LLC | $102,585,352 | 258,258 | 0.30% | 株式数 |
| BANK OF NOVA SCOTIA | $102,313,941 | 257,575 | 0.30% | 株式数 |
| RHUMBLINE ADVISERS | $102,294,748 | 257,527 | 0.30% | 株式数 |
| Sumitomo Mitsui Trust Group, Inc. | $101,464,685 | 255,437 | 0.30% | 株式数 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | $100,979,680 | 254,216 | 0.30% | 株式数 |
| Gotham Asset Management, LLC | $89,318,889 | 224,860 | 0.27% | 株式数 |
| Balyasny Asset Management L.P. | $87,965,958 | 221,454 | 0.26% | 株式数 |
| FIRST TRUST ADVISORS LP | $85,094,587 | 214,226 | 0.25% | 株式数 |
| Ensign Peak Advisors, Inc | $83,532,585 | 210,293 | 0.25% | 株式数 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $83,463,866 | 210,120 | 0.25% | 株式数 |
| Brandywine Global Investment Management, LLC | $80,388,706 | 313,859 | 0.24% | 株式数 |
| California Public Employees Retirement System | $80,274,587 | 202,091 | 0.24% | 株式数 |
| WOLVERINE TRADING, LLC | $76,135,109 | 298,300 | 0.23% | コールオプション |
| Camber Capital Management LP | $73,344,000 | 300,000 | 0.22% | 株式数 |
| National Pension Service | $70,860,473 | 178,391 | 0.21% | 株式数 |
| BARCLAYS PLC | $70,472,788 | 177,415 | 0.21% | 株式数 |
| Susquehanna Portfolio Strategies, LLC | $69,949,250 | 176,097 | 0.21% | 株式数 |
| Walleye Trading LLC | $69,473,778 | 174,900 | 0.21% | コールオプション |
| CANADA PENSION PLAN INVESTMENT BOARD | $68,018,761 | 171,237 | 0.20% | 株式数 |
| ARGA Investment Management, LP | $66,165,730 | 166,572 | 0.20% | 株式数 |
| ORBIMED ADVISORS LLC | $65,183,802 | 164,100 | 0.19% | 株式数 |
| Solel Partners LP | $64,742,888 | 162,990 | 0.19% | 株式数 |
| AMF Tjanstepension AB | $61,961,951 | 155,989 | 0.18% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $60,794,124 | 153,049 | 0.18% | 株式数 |
| Perpetual Ltd | $57,945,659 | 145,878 | 0.17% | 株式数 |
| CI INVESTMENTS INC. | $57,302,560 | 144,259 | 0.17% | 株式数 |
| AMERICAN CENTURY COMPANIES INC | $56,575,256 | 142,426 | 0.17% | 株式数 |
| Squarepoint Ops LLC | $56,047,742 | 141,100 | 0.17% | プットオプション |
| Aberdeen Group plc | $53,345,852 | 134,298 | 0.16% | 株式数 |
| WOLVERINE TRADING, LLC | $52,653,949 | 206,300 | 0.16% | プットオプション |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $52,178,000 | 131,358 | 0.15% | 株式数 |
| ING GROEP NV | $51,583,784 | 129,862 | 0.15% | 株式数 |
| Squarepoint Ops LLC | $50,685,272 | 127,600 | 0.15% | コールオプション |
| Walleye Trading LLC | $49,573,056 | 124,800 | 0.15% | プットオプション |
| D. E. Shaw & Co., Inc. | $46,514,462 | 117,100 | 0.14% | コールオプション |
| BRAIDWELL LP | $45,481,690 | 114,500 | 0.14% | 株式数 |
| Jain Global LLC | $43,694,200 | 110,000 | 0.13% | プットオプション |
| BANK OF MONTREAL /CAN/ | $43,207,208 | 108,774 | 0.13% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42,190,325 | 106,214 | 0.13% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $42,127,167 | 106,055 | 0.13% | 株式数 |
| AVIVA PLC | $41,509,093 | 104,499 | 0.12% | 株式数 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $41,468,472 | 161,904 | 0.12% | 株式数 |
| ROYAL BANK OF CANADA | $41,033,000 | 103,301 | 0.12% | 株式数 |
| Pentwater Capital Management LP | $39,722,000 | 100,000 | 0.12% | コールオプション |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $39,284,661 | 98,899 | 0.12% | 株式数 |
| Point72 Asset Management, L.P. | $39,122,595 | 98,491 | 0.12% | 株式数 |
| PFM Health Sciences, LP | $37,487,638 | 94,375 | 0.11% | 株式数 |
| Summit Street Capital Management, LLC | $36,325,372 | 91,449 | 0.11% | 株式数 |
| Columbus Hill Capital Management, L.P. | $35,501,935 | 89,376 | 0.11% | 株式数 |
| Korea Investment CORP | $34,579,193 | 87,053 | 0.10% | 株式数 |
| Quantinno Capital Management LP | $32,817,091 | 82,616 | 0.10% | 株式数 |
| Fisher Funds Management LTD | $32,811,563 | 82,603 | 0.10% | 株式数 |
| Swedbank AB | $32,034,603 | 80,647 | 0.10% | 株式数 |
企業インサイダー 76 人のインサイダー · 46人の役員 · 27人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| James A. Rechtin | President & CEO | 2025年5月14日 P | 30,474 | 0 | 0 | $0 |
| Bruce D Broussard | Chief Executive Officer | 2024年2月21日 A | 110,130 | 0 | 0 | $0 |
| Celeste Mellet | Chief Financial Officer | 2025年2月24日 A | 29,676 | 0 | 0 | $0 |
| Susan M Diamond | Chief Financial Officer | 2024年12月31日 J | 20,165 | 0 | 0 | $0 |
| Brian A Kane | Chief Financial Officer | 2021年2月22日 A | 24,342 | 0 | 0 | $0 |
| Steven E Mcculley | Interim CFO & Treasurer | 2014年5月9日 G | 14,916 | 0 | 0 | $0 |
| George Renaudin II | President, Insurance | 2025年3月27日 J | 15,702 | 0 | 0 | $0 |
| David Dintenfass | President, Enterprise Growth | 2025年2月24日 A | 16,234 | 0 | 0 | $0 |
| Sanjay K Shetty | President, CenterWell | 2025年2月24日 A | 11,566 | 0 | 0 | $0 |
| M.D. Andrew C. Agwunobi, | Seg. President, Home Solutions | 2023年2月24日 A | 182 | 0 | 0 | $0 |
| Timothy Alan Wheatley | Segment President, Retail | 2022年12月15日 M | 3,983 | 0 | 0 | $0 |
| Joseph William Jasser | Seg. President, Care Delivery | 2017年12月15日 M | 222 | 0 | 0 | $0 |
| Thomas J Liston | President - Retail Segment | 2014年2月18日 A | 105,443 | 0 | 0 | $0 |
| James E Murray | EVP & COO | 2017年3月31日 J | 34,668 | 0 | 0 | $0 |
| Japan Mehta | Chief Information Officer | 2025年2月24日 A | 8,628 | 0 | 0 | $0 |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | 2025年2月24日 A | 1,767 | 0 | 0 | $0 |
| Michelle A. O'Hara | Chief Human Resources Officer | 2025年2月24日 A | 11,266 | 0 | 0 | $0 |
| Joseph C Ventura | Chief Legal Officer | 2025年2月24日 A | 17,267 | 0 | 0 | $0 |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | 2025年2月24日 A | 16,717 | 0 | 0 | $0 |
| Timothy S. Huval | Chief Administrative Officer | 2024年12月31日 G | 7,111 | 0 | 0 | $0 |
| Samir Deshpande | Chief Information Officer | 2024年12月15日 M | 14,015 | 0 | 0 | $0 |
| William Kevin Fleming | Chief Corporate Aff. Officer | 2024年2月21日 A | 11,723 | 0 | 0 | $0 |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | 2023年2月24日 F | 3,687 | 0 | 0 | $0 |
| William H Shrank | Chief Medical Officer | 2022年5月1日 M | 4,294 | 0 | 0 | $0 |
| Cynthia H Zipperle | SVP, Chief Acct Officer & Cont | 2022年3月22日 J | 5,723 | 0 | 0 | $0 |
| Heather Cox | Chief Dig Health & Analyt Off. | 2022年2月25日 F | 6,014 | 0 | 0 | $0 |
| Christopher H. Hunter | Seg Pres. Gr. & Military Bus. | 2021年3月16日 G | 8,168 | 0 | 0 | $0 |
| Elizabeth D Bierbower | Strategic Advisor | 2019年12月18日 M | 18,092 | 0 | 0 | $0 |
| Brian P. Leclaire | Strategic Advisor | 2019年12月15日 M | 6,339 | 0 | 0 | $0 |
| Jody L Bilney | Chief Consumer Officer | 2019年2月25日 A | 9,774 | 0 | 0 | $0 |
| Roy A Beveridge, | Chief Medical Officer | 2019年2月19日 M | 10,791 | 0 | 0 | $0 |
| Todoroff M Christopher | Chief Legal Officer | 2018年12月15日 M | 11,136 | 0 | 0 | $0 |
| Heidi S Margulis | Chief Corp. Affairs Officer | 2018年12月15日 M | 6,476 | 0 | 0 | $0 |
| Christopher E Kay | SVP & Chief Innovation Officer | 2017年3月17日 M | 4,361 | 0 | 0 | $0 |
| Tim S Mcclain | Group Pres, Govt & Other Busin | 2014年2月18日 A | 1,101 | 0 | 0 | $0 |
| Bruce D Perkins | Sgmt Pres, Healthcare Services | 2014年2月18日 A | 15,946 | 0 | 0 | $0 |
| Paul B. K. Kusserow | Sr VP & Ch Strat Dev Officer | 2013年6月24日 M | 19,347 | 0 | 0 | $0 |
| HATHCOCK BONNIE C | Sr VP & Chief Human Res. Off | 2012年12月24日 G | 2,287 | 0 | 0 | $0 |
| Venkata R Madabhushi | SVP & Chief Innov & Mrkting Of | 2012年4月28日 F | 11,946 | 0 | 0 | $0 |
| GOODMAN BRUCE J | Sr. VP | 2012年2月23日 A | 23,280 | 0 | 0 | $0 |
| Jonathan T Lord MD | Sr VP & Chief Innovation Off. | 2009年2月4日 I | 0 | 0 | 0 | $0 |
| Arthur P Hipwell | Senior Vice President | 2008年3月27日 J | 302 | 0 | 0 | $0 |
| Kathleen Pellegrino | VP and Acting General Counsel | 2008年2月25日 F | 13,836 | 0 | 0 | $0 |
| Steven O Moya | Sr. VP-Chief Marketing Officer | 2007年12月31日 I | 0 | 0 | 0 | $0 |
| John M Bertko | Vice President & Chief Actuary | 2007年2月23日 M | 57,548 | 0 | 0 | $0 |
| Eugene R Shields | Senior Vice President-Gov Prgm | 2005年1月6日 M | 0 | 0 | 0 | $0 |
| Kurt J Hilzinger | 取締役 | 2026年6月30日 A | 19,448 | 0 | 0 | $0 |
| Frank A Damelio | 取締役 | 2026年1月2日 A | 20,634 | 0 | 0 | $0 |
| Karen Katz | 取締役 | 2025年12月31日 A | 590 | 0 | 0 | $0 |
| David T Feinberg | 取締役 | 2025年6月30日 A | 441 | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー;純額=公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 1保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図(アクティビストの保有、取締役会キャンペーン、M&A)を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| David A. Jones ×2 提出書類 | 2003年11月12日 | — | 初回提出 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 200のETFが保有
ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| IHF · iShares Trust | 4.29% | 144,763 SH | 2026年8月8日 | 日次 |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.95% | 109,132 NS | 2026年4月30日 | N-PORT |
| SMRI · EA Series Trust | 2.54% | 58,016 NS | 2026年4月30日 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 2.27% | 100,446 SH | 2026年8月8日 | 日次 |
| TGLB · T. Rowe Price Exchange-Traded Funds… | 2.26% | 2,111 NS | 2026年4月30日 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 1.80% | 11,546 SH | 2026年8月8日 | 日次 |
| SRHQ · Elevation Series Trust | 1.63% | 13,322 NS | 2026年4月30日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.60% | 32,564 SH | 2026年8月8日 | 日次 |
| CVAR · ETF Opportunities Trust | 1.51% | 2,473 NS | 2026年4月30日 | N-PORT |
| EPMV · Harbor ETF Trust | 1.20% | 225 NS | 2026年4月30日 | N-PORT |
| ABCS · EA Series Trust | 1.19% | 441 NS | 2026年5月29日 | N-PORT |
| MFSV · MFS Active Exchange Traded Funds Tr… | 1.14% | 17,702 NS | 2026年5月31日 | N-PORT |
| NUMV · Nushares ETF Trust | 0.96% | 17,434 NS | 2026年4月30日 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.95% | 52,223 NS | 2026年4月30日 | N-PORT |
| VOE · VANGUARD INDEX FUNDS | 0.82% | 771,237 SH | 2026年8月8日 | 日次 |
| ITAN · EA Series Trust | 0.77% | 2,259 NS | 2026年5月29日 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0.72% | 65,925 NS | 2026年5月31日 | N-PORT |
| IYH · iShares Trust | 0.72% | 71,884 SH | 2026年8月8日 | 日次 |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.71% | 183,164 SH | 2026年8月8日 | 日次 |
| VHT · VANGUARD WORLD FUND | 0.70% | 360,880 SH | 2026年8月8日 | 日次 |
| AUSF · Global X Funds | 0.70% | 19,401 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0.63% | 211 NS | 2026年5月31日 | N-PORT |
| FVAL · FIDELITY COVINGTON TRUST | 0.59% | 30,459 NS | 2026年4月30日 | N-PORT |
| IXJ · iShares Trust | 0.56% | 62,953 SH | 2026年8月8日 | 日次 |
| RXL · ProShares Trust | 0.53% | 1,258 NS | 2026年5月31日 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.47% | 2,755 NS | 2026年4月30日 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0.46% | 2,601,869 SH | 2026年8月8日 | 日次 |
| FHLC · FIDELITY COVINGTON TRUST | 0.46% | 55,439 NS | 2026年4月30日 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.45% | 28,340 NS | 2026年4月30日 | N-PORT |
| DEUS · DBX ETF Trust | 0.43% | 3,849 NS | 2026年5月29日 | N-PORT |
| IWS · iShares Trust | 0.42% | 181,221 SH | 2026年8月8日 | 日次 |
| CURE · Direxion Shares ETF Trust | 0.41% | 2,404 NS | 2026年4月30日 | N-PORT |
| SPXD · DBX ETF Trust | 0.37% | 81 NS | 2026年5月31日 | N-PORT |
| IMCV · iShares Trust | 0.36% | 11,394 SH | 2026年8月8日 | 日次 |
| QARP · DBX ETF Trust | 0.36% | 887 NS | 2026年5月29日 | N-PORT |
| VRP · Invesco Exchange-Traded Fund Trust … | 0.35% | 10,520,000 | 2026年8月8日 | 日次 |
| PRF · Invesco Exchange-Traded Fund Trust | 0.35% | 90,057 SH | 2026年8月8日 | 日次 |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.34% | 4,484 NS | 2026年5月31日 | N-PORT |
| GMOV · GMO ETF Trust | 0.34% | 1,004 NS | 2026年5月31日 | N-PORT |
| FNDX · SCHWAB STRATEGIC TRUST | 0.32% | 265,500 NS | 2026年5月31日 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0.32% | 7,839 SH | 2026年8月8日 | 日次 |
| IWR · iShares Trust | 0.32% | 489,015 SH | 2026年8月8日 | 日次 |
| IMCB · iShares Trust | 0.30% | 13,840 SH | 2026年8月8日 | 日次 |
| FNDB · SCHWAB STRATEGIC TRUST | 0.29% | 12,439 NS | 2026年5月31日 | N-PORT |
| PALC · Pacer Funds Trust | 0.29% | 2,779 NS | 2026年4月30日 | N-PORT |
| SPVU · Invesco Exchange-Traded Fund Trust … | 0.28% | 1,250 NS | 2026年5月31日 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0.28% | 320,000 | 2026年8月8日 | 日次 |
| BRCE · MFS Active Exchange Traded Funds Tr… | 0.27% | 299 NS | 2026年5月31日 | N-PORT |
| FFLC · FIDELITY COVINGTON TRUST | 0.26% | 12,272 NS | 2026年4月30日 | N-PORT |
| VLUE · iShares Trust | 0.24% | 62,558 SH | 2026年8月8日 | 日次 |